At the 2015 AACC Annual Meeting & Clinical Lab Expo, researchers will present findings that a first-of-its-kind smartphone test for chlamydia can detect the disease with high accuracy, which could reduce the prevalence of this sexually transmitted disease (STD) by making chlamydia screening easier and cheaper.
Clinical laboratory tests play a crucial role in making sure patients get appropriate care, yet many small labs and clinics in low resource settings cannot afford the instruments needed to provide these tests. Research on a novel fingerprick test that can perform all common clinical diagnostics could help to expand access to basic medical testing in the developing world, and will be featured at the 2015 AACC Annual Meeting & Clinical Lab Expo.
Researchers have successfully tested two new potential methods for diagnosing and monitoring diabetes in its standard and gestational forms. These findings, presented today at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta, may lead to easier, timelier, and more affordable ways of identifying and treating this chronic disease.
Hair samples can be used to measure the effects of asthma on the cortisol levels of women during pregnancy, according to research presented today at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta. This research also shows that levels of cortisol, a stress-related hormone, tend to be lower among pregnant women with asthma than among pregnant women without the chronic, inflammatory lung disease.
AACC is pleased to announce the recipients of the AACC 2015 Corporate Supporter Awards. Each year, AACC recognizes the companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
Research presented at the 2015 AACC Annual Meeting & Clinical Lab Expo will expand on the studies that led to a fingerprick Ebola test becoming the first and only rapid diagnostic for this disease to receive approval from the World Health Organization (WHO). This test could prove vital to breaking Ebola’s grip on West Africa by identifying suspected Ebola cases within minutes, and enabling healthcare workers to isolate and treat these patients much faster than is currently possible.
The 2015 AACC Annual Meeting & Clinical Lab Expo, the leading annual event for laboratory medicine, will open on Sunday, July 26, in Atlanta, Georgia. This year’s meeting will host more than 400 educational sessions on topics ranging from personalized medicine and infectious diseases to point-of-care and laboratory-developed tests, and will feature more than 200 new cutting edge diagnostic products.
Noting a paradigm shift among consumers who are seeking greater control over their own healthcare, AACC issued a position statement today on direct-to-consumer laboratory testing, which allows people to order medical tests directly from a lab without having to work with their healthcare provider. The statement emphasizes direct-to-consumer test results must be accurate and easily understood—an area where laboratory medicine professionals play a vital role.
Streck will be a sponsor and exhibitor at the AACC Annual Meeting & Clinical Lab Expo. Streck has a number of new products this year; find us at booth #2552 to learn more
As BBI Solutions (BBI) prepare for its 25th consecutive attendance at AACC, visitors to the BBI booth can expect to discover the increasing importance of high quality biological raw materials in driving assay performance and how BBI’s new, innovative products can help achieve this.
The BBI Group (BBI) today announced it has developed in collaboration with the Defence Science and Technology Laboratory (Dstl) and licensed, through technology transfer company Ploughshare Innovations, a rapid test for Ebola. The assay, which is in the process of being verified to allow EUA submission, will be used to test patients suspected of Ebola infection to screen and potentially help with how they are subsequently managed. The test, utilising lateral flow technology, can provide a result in approximately 20 minutes.
Enigma Diagnostics Ltd. (Enigma) and Beijing Leadman Biochemistry Co., Ltd. (Beijing Leadman) (SZSE:300289) signed a joint venture agreement with the principal goal of delivering the Enigma MiniLab molecular diagnostic Point-of-Care platform into the Chinese health care market to support its growing diagnostic needs.
Parker Hannifin Corporation announces the release of the R9 Diaphragm Rocker Isolation Liquid Valve, a family of 9 mm valves that improves performance of Clinical Diagnostic, Analytical Chemistry and Agent Detection systems requiring precision fluid control
— Visiun, Inc., the leader in performance analytics for the laboratory, announced today that the Compass Group has awarded them a sole source agreement for business intelligence software for their 26 health systems, encompassing over 380 hospitals nationwide. Following a vendor evaluation process, the Compass Group selected Visiun’s feature-rich Performance Insight™.
Visiun, Inc., the leader in performance analytics for the laboratory, is celebrating 5 years of proudly supporting the laboratory community and will be showcasing their feature-rich Performance Insight™ at the AACC Clinical Lab Expo, taking place July 28-30, at the Georgia World Congress Center in Atlanta, Georgia
Beckman Coulter will be showing the Aquios CL Flow Cytometer and setting up one-to-one demonstrations at their Booth #521 during the 2015 AACC Annual Meeting & Clinical Lab Expo to be held in Atlanta, Georgia, July 28-30, 2015.
Marker Test Diagnostics, Inc., a leading international supplier to the drug testing industry, announced today that the company has completed a corporate relocation for its U.S. headquarters from Leesburg, Va. to Chandler, Az.
The CrAg Lateral Flow Assay (LFA) a novel, rapid diagnostic test, is playing a crucial role in saving lives all over the world. The CrAg LFA tests for an infection called Cryptococcosis, which kills over 600,000 people every year, primarily in HIV/AIDS patients. Because of the ease-of-use and room temperature storage, the CrAg LFA, developed by IMMY, is the only test capable of bridging the gap between this disease and the life-saving medicine these patients need.
Festo displays at AACC 2015 at the World Congress Center in Atlanta, July 28-30, its high-speed, precise, automated handling system for clinical laboratory applications – the EXCM mini H-gantry. Festo also presents a number of systems designed to automate clinical laboratory processes.
Marker Test Diagnostics, Inc., a leading international supplier to the drug testing industry, has secured its first agreement to distribute its UR Code urine marker product in the U.S. with Elithea Sciences, a leading provider of drug confirmation testing, toxicology and analytical services.
The new LPD Series Stepper Dispense Pump is the latest variable volume pump offered by The Lee Company.
The Lee Company continues to redefine miniature fluidics with the introduction of an even more compact High Density Interface (HDI) solenoid valve
Visiun, Inc., the leader in performance analytics for the laboratory, announced today the release of a utilization management reporting system for laboratories nationwide. This new solution will help laboratories identify opportunities to eliminate unnecessary testing. In an environment of decreasing reimbursements, test utilization represents one of the greatest opportunities for laboratories to improve financial performance.
Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announced today that it has entered into a partnership agreement with Hospira regarding the supply of LISA-TRACKER’s CE-marked infliximab monitoring kit.
Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announced today that it has obtained CE marking for its monitoring test of Stelara® (ustekinumab), the 10thbiotherapy monitoring test of Theradiag’s LISA TRACKER range.
Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics andin vitro diagnostics, announces today that it has entered into a master services agreement with the biopharmaceutical company UCB, with a first application for the anti-TNF biologic certolizumab pegol (the brand name Cimzia®).
Streck introduces Temp-Chex Digital II, a thermometer built to withstand a wide temperature range suitable for freezers, refrigerators and incubators.
The Lee Company’s new LFY2 Inert Solenoid Valve is the latest addition to Lee’s field proven Y-Valve product line
Precision Die Cutting, with operations in Chino, California and in Singapore, has become the Industry leader in providing support to OEM companies the Lateral Flow/ IVD market. They have a 10+ year history providing their industry approved "KN2211 adhesive" laminated to various plastic backings. They also supply custom printed cover tapes and other custom converted components.
In 2012 Maine Biotechnology Services entered into a partnership with Drs. Mark Heise and Kristen Long of the University of North Carolina Medical School, with the objective of developing monoclonal antibodies to support ongoing research efforts to advance adequate vaccine and rapid detection methods for Chikungunya virus, an emerging global infection. MBS is announcing the release of three monoclonal antibodies resulting from that partnership. The 181/25 vaccine strain of CHKV was used as the immunogen and all three antibodies detect active strains of Chikungunya virus by ELISA. In addition to recognizing the immunizing vaccine strain 181/25 by ELISA, these clones also to the CHIKV strain originating in Sri Lanka. Further ELISA data indicates that the antibodies do not cross-react with other alphaviruses including Mayaro, Ross River and O’nyong-nyong viruses. Applications for these antibodies include the detection of active virus either in circulation or in mosquito carriers.MAB243P
MBS has added a new norovirus antibody to a diagnostic panel that now includes seven monoclonal antibodies. MAB242P, the most recently developed antibody, is the first MBS antibody to recognize both GI and GII strains of norovirus. MAB242P complements our previous offering of antibodies that were exclusive for either GI or GII strains of the virus. With this complete panel, MBS now meets customers’ broad and diverse diagnostic goals.
Maine Biotechnology Services is announcing the addition of Bacterial Recombinant Protein Expression and Purification services to compliment our complete antibody service offering, adding value and efficiency to custom antibody development with MBS.
Medical Electronic Systems (MES) today announced the worldwide release of the SQA-Vision, the company’s new automated sperm quality analyzer. The SQA-Vision was developed based on 10 years of market feedback and is positioned to augment the company’s line of SQA-V and QwikCheck™ semen analyzers with a top of the line solution. Some of the enhanced features of the SQA-Vision include a high definition touch screen interface, expanded testing options and state of the art digital magnification with ‘Click-to-Mark’ interface.
As one of the premiere companies in the medical device industry, Mindray in 1997 ventured into and found success in the In-Vitro Diagnostic business. After more than 20 years of dedication, Mindray today is one step closer to offering end-users a total solution of Hematology.
Streck introduces CD-Chex CD103™ Plus, the only commercially available flow cytometry control that includes CD103, CD30, CD38, CD56, CD138, and Cytoplasmic Lambda in a single control, and the only control on the market to provide reference values for CD138.
Streck has introduced a new flow cytometry control, CD-Chex TdT Plus. It is the only commercially available flow cytometry control assayed for TdT, CD1a, CD34 and cCD3 in a single control.
Every application is different and has its individual requirements. This is why Diener Precision Pumps, the Swiss quality manufacturer of gear pumps and piston pumps, designs and produces also the manifolds exactly to individual specifications.
Fluid systems in medical devices are becoming compact and more sophisticated. The traditionally used syringe pumps seem no longer able to keep up with the new requirements in terms of size, cost and performance. Valve-less piston pumps that combine the benefits of syringe pumps with lower cost and higher performance, could be the solution of the future. Diener Precision Pumps will present a live demo of valve-less piston pumps at the AACC Annual Meeting & Clinical Lap Expo in Atlanta, Georgia/USA in July.
The Lee Company’s new LPG Series Inert Solenoid Pump was designed to offer greater design flexibility and significant cost savings to the medical and scientific industries.
The Diatron Group,a global provider of hematology and clinical chemistry analyzers, will display its new economic walk-away clinical chemistry analyzer, the Pictus P500, at the AACC, Atlanta (28-30 July 2015), on booth No 2100.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right